Review
Aug 2026
The neuro-immune-tumor axis in head and neck squamous cell carcinoma.
It is proposed that targeting neural signaling, through drug repurposing or neuro-immunotherapy combinations, represents a promising strategy to overcome the immunosuppressive TME and improve patient outcomes in HNSCC.
L. Zhang, M. Yamazaki, J. Tanuma et al.
· Critical reviews in oncology... · 0 citations